5 Companies Redefining Therapeutic Options for Cervical Cancer
Cancer is the second leading cause of death in the U.S, next only to heart diseases. An estimated 1.7 million new cancer cases...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
TOMI Environmental Solutions is Leveraging its Patented Technology to Combat COVID-19
TOMI Environmental Solutions (OTCQB: TOMZ), a Company that offers indoor and outdoor disinfection and decontamination services globally, announced a partnership with Rock Emergency,...
Can Superior Yield and Potency Help Charlotte’s Web Holdings Buck the Trend?
Charlotte’s Web Holdings (OTCQX: CWBHF), a pioneer in hemp-derived CBD products, announced the completion of an audit of its 2019 hemp harvest, which...
RADA Electronics Making A Mark On The Global Radar Market
RADA Electronic Industries (NASDAQ: RADA), a global defense technology Company offering leading-edge radar solutions and legacy avionics systems, announced the manufacture of the...
Fennec Pharmaceuticals is gaining steam in its quest for commercializing PEDMARK
Fennec Pharmaceuticals (NASDAQ: FENC), a small–stage biotechnology Company, announced the grant of a patent 10,596,190 entitled “Method for Reducing Ototoxicity in Pediatric Patients...
5 Exciting Stocks to Watch Out for in 2020
The Global Stock markets are currently facing the fallout from wide-spread pandemonium owing to the coronavirus scare. The outbreak has affected trade and...
Zosano gets Crucial FDA Nod for New Drug Application for Qtrypta™ for Acute Treatment of Migraine
Zosano Pharma (NASDAQ: ZSAN), a clinical-stage biopharmaceutical Company, announced the acceptance of the Company’s New Drug Application for Qtrypta™, a proprietary formulation of...
Altimmune leveraging novel intranasal technology in the race against coronavirus
Altimmune Inc (NASDAQ: ALT), a clinical stage biotechnology Company developing immunotherapies for unmet medical needs, announced that the Company has completed designing and...
Zelira Therapeutics Aims to Disrupt the Global Medical Cannabis Market
Zelira Therapeutics (OTCQB: ZLDAF), a biopharmaceutical Company developing cannabinoid-based formulations for the treatment of a wide range of medical conditions, announced full enrollment...
